Amid Delivery Tech Dispute, Alnylam Forges Collaboration with Precision NanoSystems | GenomeWeb

Alnylam Pharmaceuticals announced this week that it has forged an exclusive collaboration with Vancouver, Canada-based Precision Nanosystems to discover and develop novel small lipid nanoparticles using microfluidics, marking the latest in a series of delivery-focused collaborations inked over the past year.

According to the companies, Precision NanoSystems' LNPs are roughly 20 nanometers in size, opening the door to effective siRNA delivery to organs and tissues beyond the liver. Additional terms of the arrangement were undisclosed.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.